Interleukin-1β Inhibition for Chronic Kidney Disease in Obese Mice With Type 2 Diabetes
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-1β Inhibition for Chronic Kidney Disease in Obese Mice With Type 2 Diabetes
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-05-29
DOI
10.3389/fimmu.2019.01223
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
- (2018) Hiddo J.L. Heerspink et al. KIDNEY INTERNATIONAL
- Therapeutic vaccine against IL-1β improved glucose control in a mouse model of type 2 diabetes
- (2018) Yue Zhang et al. LIFE SCIENCES
- CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
- (2018) Hans-Joachim Anders et al. Nature Reviews Nephrology
- Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications
- (2018) Arpeeta Sharma et al. Frontiers in Physiology
- Anti-Transforming Growth Factor β IgG Elicits a Dual Effect on Calcium Oxalate Crystallization and Progressive Nephrocalcinosis-Related Chronic Kidney Disease
- (2018) Stefanie Steiger et al. Frontiers in Immunology
- NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice
- (2018) Ming Wu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients
- (2017) Hemat El-Sayed El-Horany et al. IUBMB LIFE
- The diabetes pandemic suggests unmet needs for ‘CKD with diabetes’ in addition to ‘diabetic nephropathy’–implications for pre-clinical research and drug testing
- (2017) Lidia Anguiano Gómez et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus
- (2017) Yao Wang et al. PLoS One
- Transcriptome-based network analysis reveals renal cell type-specific dysregulation of hypoxia-associated transcripts
- (2017) Natallia Shved et al. Scientific Reports
- Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset
- (2016) Susanne M. Cabrera et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance
- (2016) Robin P. Choudhury et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Of Inflammasomes and Alarmins: IL-1 and IL-1 in Kidney Disease
- (2016) H.-J. Anders JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Improved kinetic model for the transcutaneous measurement of glomerular filtration rate in experimental animals
- (2016) Jochen Friedemann et al. KIDNEY INTERNATIONAL
- C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria
- (2016) Jan Menne et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Nephron Protection in Diabetic Kidney Disease
- (2016) Hans-Joachim Anders et al. NEW ENGLAND JOURNAL OF MEDICINE
- Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy
- (2016) Yuan-ye Qiu et al. PHARMACOLOGICAL RESEARCH
- Optimizing Mouse Surgery with Online Rectal Temperature Monitoring and Preoperative Heat Supply. Effects on Post-Ischemic Acute Kidney Injury
- (2016) Julian A. Marschner et al. PLoS One
- Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications
- (2015) S. Kumar VR et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
- (2015) Khurrum Shahzad et al. KIDNEY INTERNATIONAL
- The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial
- (2015) Dick de Zeeuw et al. Lancet Diabetes & Endocrinology
- Pattern recognition receptors and the inflammasome in kidney disease
- (2014) Jaklien C. Leemans et al. Nature Reviews Nephrology
- Long-Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis
- (2013) Daniel J. Lovell et al. ARTHRITIS AND RHEUMATISM
- Impact of interleukin-1β antibody (canakinumab) on glycaemic indicators in patients with type 2 diabetes mellitus: Results of secondary endpoints from a randomized, placebo-controlled trial
- (2013) J. Hensen et al. DIABETES & METABOLISM
- Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
- (2013) Antoinette Moran et al. LANCET
- Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions
- (2012) Naomi Schlesinger et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen
- (2012) Paul M Ridker et al. CIRCULATION
- Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
- (2012) C. Cavelti-Weder et al. DIABETES CARE
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Nicolino Ruperto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dual Blockade of the Homeostatic Chemokine CXCL12 and the Proinflammatory Chemokine CCL2 Has Additive Protective Effects on Diabetic Kidney Disease
- (2011) Murthy N. Darisipudi et al. AMERICAN JOURNAL OF PATHOLOGY
- XOMA 052, an Anti-IL-1β Monoclonal Antibody, Improves Glucose Control and β-Cell Function in the Diet-Induced Obesity Mouse Model
- (2010) Alexander M. Owyang et al. ENDOCRINOLOGY
- Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice
- (2010) M. Lech et al. INTERNATIONAL IMMUNOLOGY
- Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10
- (2010) Sufyan G. Sayyed et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Interleukin-1 Resets Glucose Homeostasis at Central and Peripheral Levels: Relevance for Immunoregulation
- (2010) Hugo O. Besedovsky et al. NEUROIMMUNOMODULATION
- Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
- (2009) Helen J. Lachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Late Onset of Ccl2 Blockade with the Spiegelmer mNOX-E36–3′PEG Prevents Glomerulosclerosis and Improves Glomerular Filtration Rate in db/db Mice
- (2008) Volha Ninichuk et al. AMERICAN JOURNAL OF PATHOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started